OCD Trial, Recruiting NCT07558148 Sponsor: University of Pennsylvania Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT07558148
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 60 years old
  • You have been diagnosed with OCD (according to standard medical guidelines) for at least 5 years before joining
  • Your OCD involves obsessions, compulsions, or both, and these take up more than one hour a day or seriously affect your daily life, work, or relationships
  • Your OCD symptoms are not caused by a drug, medication, or other medical condition
  • Your symptoms are not better explained by a different mental health condition
  • Your OCD is considered severe, based on a specific scoring tool called the Y-BOCS (a score of 28 or higher, measured within two weeks before joining)
  • Your compulsions involve physical movement of your hands and/or arms (since the study device needs to detect movement — compulsions that are only mental or verbal do not qualify)
  • You are able to understand and follow study instructions in English
  • You are willing and able to allow the research team to communicate with your doctor(s)
  • You are willing and able to give written informed consent to participate

Who may not be able to join:

  • You are unable to have an MRI scan — for example, because you have metal implants, devices, or certain tattoos; because you experience claustrophobia or severe anxiety in enclosed spaces; or because you are unable to stay still for the duration of the scan
  • You are unable to wear the study device (called ATTN201) for the required amount of time (confirm with trial site)
  • You have hearing loss that may affect your ability to take part in the study or could affect the study results, in the opinion of the study team
  • You are currently pregnant
  • You have any past or current medical condition, illness, or injury that, in the opinion of the study team, could affect your ability to complete the study or could affect the quality of the results
  • You have had a past injury or surgery that could affect how nerves are distributed in your body
  • You have nerve damage (also called neuropathy)
  • You have a diagnosed condition affecting your nerves and muscles (neuromuscular disorder)
  • You have a pacemaker
  • You have a history of skin conditions such as allergies, psoriasis, eczema, dermatitis, or other types of skin inflammation
  • Your compulsions are entirely mental or verbal (such as silently counting, repeating words in your head, or mental rituals), or involve only facial movements such as blinking or staring

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Katherine Scangos, MD, PhD, University of Pennsylvania

Phone: 215-746-8901

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 March 2026
Est. completion
19 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Symptom Intensity through VAS score; Changes in Imaging between Pre- and Post-Intervention; Incidence of Adverse Events Assesed by Symptom Checklist

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov